Application of subthreshold laser therapy in retinal diseases: a review
- 11 December 2018
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Ophthalmology
- Vol. 13 (6) , 311-320
Abstract
Introduction: Laser photocoagulation has been a valuable tool in the ophthalmologist’s armamentarium for decades. Conventional laser photocoagulation relies on visible retinal burns as a treatment end point, which is thought to result in photocoagulative necrosis of retinal tissue. Recent studies have suggested that using subthreshold (ST) laser, which does not cause detectable damage to the retina, may also have therapeutic effects in a variety of retinal diseases.Areas covered: We review the proposed biological mechanisms mediating the therapeutic effects of ST laser on the retina, followed by the evidence for ST laser efficacy in retinal diseases such as diabetic macular edema (DME), central serous chorioretinopathy, age-related macular degeneration, and retinal vein occlusion. Expert commentary: Multiple clinical studies demonstrate that ST laser does not cause structural damage to the retina based on multimodal imaging. Evidence suggests that there is a therapeutic effect on decreasing DME and subretinal fluid in chronic central serous retinopathy; however, the effect may be relatively modest and is not as efficacious as first-line treatments for these diseases. Given the repeatability and lack of damage to the retina by this treatment, ST laser deserves further study to determine its place in the retina specialist’s armamentarium.Keywords
Funding Information
- National Eye Institute (1K12EY024225-01A1)
This publication has 83 references indexed in Scilit:
- The Comparative Histologic Effects of Subthreshold 532- and 810-nm Diode Micropulse Laser on the RetinaInvestigative Ophthalmology & Visual Science, 2013
- Glial Cell and Inflammatory Responses to Retinal Laser Treatment: Comparison of a Conventional Photocoagulator and a Novel, 3-Nanosecond Pulse LaserInvestigative Ophthalmology & Visual Science, 2013
- IMPROVEMENT IN VISUAL ACUITY AND CONTRAST SENSITIVITY IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY AFTER MACULAR SUBTHRESHOLD LASER THERAPYRetina, 2013
- Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathyJournal of Clinical Investigation, 2012
- Subthreshold Laser Treatment Versus Threshold Laser Treatment for Symptomatic Retinal Arterial MacroaneurysmInvestigative Ophthalmology & Visual Science, 2012
- Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathyEye, 2011
- LONG-TERM SD-OCT/SLO IMAGING OF NEURORETINA AND RETINAL PIGMENT EPITHELIUM AFTER SUBTHRESHOLD INFRARED LASER TREATMENT OF DRUSENRetina, 2011
- MICROPERIMETRY AND FUNDUS AUTOFLUORESCENCE IN DIABETIC MACULAR EDEMARetina, 2010
- RETINAL PIGMENT EPITHELIUM PRODUCES MATRIX METALLOPROTEINASES AFTER LASER TREATMENTRetina, 2007
- Prophylactic Treatment of Age-Related Macular Degeneration Report Number 1: 810-Nanometer Laser to Eyes with Drusen. Unilaterally Eligible PatientsOphthalmology, 2006